Relapsed Adult Acute Myeloid Leukemia Completed Phase 1 Trials for LY-2874455 (DB13022)

IndicationStatusPhase
DBCOND0075222 (Relapsed Adult Acute Myeloid Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03125239Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaTreatment